Literature DB >> 2479658

Demyelination and early remyelination in experimental allergic encephalomyelitis passively transferred with myelin basic protein-sensitized lymphocytes in the Lewis rat.

M P Pender1, K B Nguyen, D O Willenborg.   

Abstract

Histological studies were performed on Lewis rats with experimental allergic encephalomyelitis (EAE) passively transferred by myelin basic protein (MBP)-sensitized syngeneic spleen cells in order to determine the relationship between demyelination and neurological signs. Neither inflammation nor demyelination was present on the day prior to the onset of neurological signs but both were present in the spinal roots and spinal cord on the day of onset of tail weakness (4 days after passive transfer). Demyelination and the neurological signs both increased over the next 48 h. There was evidence that the caudal roots were more severely affected than the rostral roots. The peripheral nerves were spared. Demyelination in the spinal cord was concentrated in the dorsal root entry and ventral root exit zones. The initial stages of repair of demyelinated spinal root fibres by Schwann cells were observed on the earliest day that clinical recovery commenced (day 7). At this time some demyelinated fibres were closely associated with debris-free Schwann cells, and occasional fibres were completely invested by 1-2 layers of Schwann cell cytoplasm. Remyelination (compact myelin lamellae formation) by Schwann cells was first observed in the spinal roots on day 9. By the time of complete clinical recovery (day 11) the majority of affected spinal root cores had thin new myelin sheaths. Repair of central nervous system myelin by oligodendrocytes was slower than peripheral nervous system myelin repair. Investment of demyelinated spinal cord axons by oligodendrocytes was observed on day 9, and remyelination by these cells was seen on day 10. We conclude that the neurological signs of passively induced MBP-EAE can be accounted for by demyelination of the lumbar, sacral and coccygeal spinal roots and spinal cord root entry and exit zones, and that the subsequent clinical recovery can be explained by investment and remyelination of demyelinated peripheral and central nervous system fibres by Schwann cells and oligodendrocytes respectively.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479658     DOI: 10.1016/0165-5728(89)90130-6

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

1.  T-cell-mediated disruption of the neuronal microtubule network: correlation with early reversible axonal dysfunction in acute experimental autoimmune encephalomyelitis.

Authors:  Leah P Shriver; Bonnie N Dittel
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

2.  The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A.

Authors:  M P Pender; G P Stanley; G Yoong; K B Nguyen
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  The proximal peripheral nervous system is a major site of demyelination in experimental autoimmune encephalomyelitis induced in the Lewis rat by a myelin basic protein-specific T cell clone.

Authors:  M P Pender; Z Tabi; K B Nguyen; P A McCombe
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.

Authors:  Ajaib S Paintlia; Manjeet K Paintlia; Inderjit Singh; Robert B Skoff; Avtar K Singh
Journal:  Glia       Date:  2009-01-15       Impact factor: 7.452

Review 5.  Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits?

Authors:  Civia Z Chen; Björn Neumann; Sarah Förster; Robin J M Franklin
Journal:  Open Biol       Date:  2021-01-27       Impact factor: 6.411

6.  Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis.

Authors:  Minodora O Totoiu; Gabriel I Nistor; Thomas E Lane; Hans S Keirstead
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.